Indications
Treatment of relapsing remitting multiple sclerosis in adult patients.
Composition
- Active substance
- peginterferon beta-1a
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Plegridy
- Active substance
- peginterferon beta-1a
- ATC code
- L03AB13
- Therapeutic area
- Multiple Sclerosis
- Marketing authorisation holder
- Biogen Netherlands B.V.
- Status
- Authorised
- EU authorisation
- 18 Jul 2014
- EMA product number